Today: 7 February 2026
Subscribe
Browse Category

Medical Technology News 13 January 2026 - 23 January 2026

Intuitive Surgical stock jumps premarket after earnings beat, but 2026 tariff hit gets attention

Intuitive Surgical stock jumps premarket after earnings beat, but 2026 tariff hit gets attention

Intuitive Surgical shares jumped 3.6% premarket to $545 after beating fourth-quarter estimates and reporting an 18% rise in global procedures. The company forecast slower 2026 procedure growth of 13%–15% and said tariffs would cut margins by about 1.2% of revenue. Traders are watching for analyst updates at the open. Cash and investments totaled $9.03 billion at year-end.
23 January 2026
····
Intuitive Surgical stock whipsaws after Q4 beat as 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical stock whipsaws after Q4 beat as 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical shares rose 0.4% to $525.81 in after-hours trading Thursday after quarterly earnings beat forecasts. The company reported a 19% revenue increase to $2.87 billion, with da Vinci procedures up 17%. Intuitive projects 13%-15% da Vinci procedure growth in 2026 but warned tariffs could cut margins. Investors remain focused on procedure growth and tariff impacts ahead of Friday’s session.
23 January 2026
·····
Intuitive Surgical Q4 2025 earnings beat lifts ISRG, but 2026 da Vinci forecast slows on tariffs

Intuitive Surgical Q4 2025 earnings beat lifts ISRG, but 2026 da Vinci forecast slows on tariffs

Intuitive Surgical reported Q4 revenue up 19% to $2.87 billion and adjusted earnings of $2.53 per share, beating analyst estimates. Shares rose about 3% in after-hours trading. The company forecast 13% to 15% growth in da Vinci procedures for 2026, slower than 2025, and warned tariffs may pressure margins. Intuitive installed 532 da Vinci systems in the quarter, ending 2025 with 11,106 in use.
22 January 2026
·····
Intuitive Surgical stock ticks up ahead of earnings after a bruising slide — what traders watch next

Intuitive Surgical stock ticks up ahead of earnings after a bruising slide — what traders watch next

Intuitive Surgical shares rose 0.9% to $528.38 Thursday ahead of fourth-quarter earnings, after a recent slide left the stock 14% below its 52-week high. Investors are focused on growth in da Vinci procedures for 2026 after last week’s cautious outlook. The company reported preliminary Q4 revenue of $2.87 billion, up 19% year over year. Results and management commentary are due after the bell.
22 January 2026
·····
Abbott (ABT) stock price ticks higher as heart-device news lands ahead of earnings — what investors watch

Abbott (ABT) stock price ticks higher as heart-device news lands ahead of earnings — what investors watch

Abbott Laboratories shares rose 0.2% to $121.34 midday Wednesday, lagging broader healthcare gains ahead of Thursday’s earnings report. The company secured EU clearance for its TactiFlex Duo ablation catheter and announced a partnership with AtaCor Medical to develop an extravascular defibrillator. Investors await guidance on 2026 and updates on the $21 billion Exact Sciences acquisition.
21 January 2026
·····
Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical shares fell 1.5% to $526.76 Tuesday afternoon, mirroring broader U.S. market declines. The company is set to report earnings Jan. 22 after signaling da Vinci procedure growth of 13%–15% in 2026 and preliminary Q4 revenue near $2.87 billion. Investors remain focused on procedure outlook and competition from Medtronic and Johnson & Johnson.
20 January 2026
·····
Intuitive Surgical stock (ISRG) heads into earnings week after Friday drop — what to watch next

Intuitive Surgical stock (ISRG) heads into earnings week after Friday drop — what to watch next

Intuitive Surgical shares fell 1.2% to $535 on Friday, marking five straight sessions of losses as trading volume rose. The company reported preliminary Q4 revenue of $2.87 billion, up 19% year-over-year, and a 17% increase in da Vinci procedures. CEO Dave Rosa said da Vinci 5 usage is 11% higher than the Xi model. Full Q4 results are due Jan. 22.
17 January 2026
·····
Intuitive Surgical stock slips again as 2026 da Vinci outlook hangs over ISRG ahead of earnings

Intuitive Surgical stock slips again as 2026 da Vinci outlook hangs over ISRG ahead of earnings

Intuitive Surgical shares fell 0.9% to $536.49 in early New York trading Friday after the company’s 2026 da Vinci procedure-growth forecast missed some investor expectations. The company reported unaudited Q4 revenue of $2.87 billion, up 19%, and projected 2026 da Vinci procedure growth of 13% to 15%. Investors await more detail at the Jan. 22 earnings call.
16 January 2026
·····
Intuitive Surgical stock slips again as 2026 da Vinci outlook keeps pressure on ISRG

Intuitive Surgical stock slips again as 2026 da Vinci outlook keeps pressure on ISRG

Intuitive Surgical shares fell 1% to $541.08 Thursday after the company warned of slower da Vinci procedure growth in 2026. The company preannounced Q4 revenue of $2.87 billion, up 19% year-over-year, and forecast 2025 revenue of $10.06 billion. UBS maintained its Neutral rating. Investors await full results on Jan. 22.
15 January 2026
·····
TransMedics stock jumps as SEC filing details $23.9 million-a-year lease for new Massachusetts HQ

TransMedics stock jumps as SEC filing details $23.9 million-a-year lease for new Massachusetts HQ

New York, Jan 13, 2026, 12:08 EST — Regular session Shares of TransMedics Group climbed roughly 8% Tuesday following new disclosures about a long-term headquarters lease and land acquisitions next door in Massachusetts. The stock hit $151.70 during the session before pulling back to $145.68. This move is significant as it sets clear figures on a substantial, long-term expense just as investors demand concrete spending plans from medical device firms, not just promises. It also comes during J.P. Morgan Healthcare Conference week, a period when healthcare execs often tweak outlooks subtly, triggering market ripples. A recent regulatory filing revealed that
13 January 2026
·····
DexCom stock jumps in premarket after early Q4 sales and 2026 outlook; what DXCM investors watch next

DexCom stock jumps in premarket after early Q4 sales and 2026 outlook; what DXCM investors watch next

NEW YORK, Jan 13, 2026, 7:52 AM ET — Premarket DexCom shares climbed roughly 5% in premarket action Tuesday, buoyed by new guidance that thrust the diabetes-device company back into focus as earnings season kicks off. (StreetInsider.com) DexCom’s preliminary Q4 update offers investors an early glimpse at 2026 revenue growth, following a stretch where talk around guidance hurt the stock more than actual results. Shares tumbled sharply in late October after execs cautioned that 2026 growth might come in just under current forecasts. (Reuters) Tuesday’s action came amid a nervous market backdrop. U.S. stock index futures slipped slightly before the
13 January 2026
·····
1 2 3 4 … 6

Stock Market Today

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

Walmart stock jumps to $131 as traders brace for CPI and Feb. 19 earnings

7 February 2026
Walmart shares rose 3.3% Friday to $131.18, up 10% since Jan. 30, as the Dow closed above 50,000 for the first time. The retailer’s market value crossed $1 trillion this week. Investors await January inflation data on Feb. 13 and Walmart’s quarterly results on Feb. 19 for signs of continued momentum.
Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

Caterpillar stock price jumps 7% to $726 as Dow cracks 50,000 — what matters next week

7 February 2026
Caterpillar shares surged 7.1% to $726.20 Friday, driving the Dow above 50,000 for the first time. The move erased recent losses and followed insider selling by Group President Bob De Lange earlier in the week. Deere and CNH Industrial also gained as investors rotated into industrial stocks. Markets await next week’s U.S. jobs and inflation data.
Amazon stock slides as $200B AI spending plan meets cautious profit outlook

Amazon stock slides as $200B AI spending plan meets cautious profit outlook

7 February 2026
Amazon shares fell 9% Friday after the company announced plans for $200 billion in 2026 capital spending, mainly for AWS and AI, and issued a first-quarter profit outlook below estimates. The stock drop could erase $200 billion in market value. Fourth-quarter net sales rose 14% to $213.4 billion, while free cash flow declined due to higher spending on AI infrastructure.
Go toTop